Bryn Mawr Trust Advisors, LLC

Position in NVS — Novartis AG

CIK 1700481 PHILADELPHIA, PA

Position in NVS

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$926,058

+$9,253 QoQ

Shares Held

5,909

-1.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#646

of 1,603 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 36% Shared 0% None 64%

Healthcare · as of Jun 30, 2026

Bryn Mawr Trust Advisors, LLC holds $73,679,493 across 10 Drug Manufacturers - General names. NVS ranks #8 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	220,148	$28,289,018
2	JNJ	Johnson & Johnson	107,673	$27,345,711
3	AZN	Astrazeneca PLC	27,799	$5,271,246
4	LLY	ELI LILLY & Co	3,407	$4,086,458
5	AMGN	Amgen Inc	9,560	$3,461,867
6	ABBV	AbbVie Inc.	8,879	$2,234,311
7	PFE	Pfizer Inc	49,991	$1,203,783
8	NVS	Novartis AG This page	5,909	$926,058

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$926,058	5,909	-1.5%	Shares	Sole	2026-08-03
2026-03-31	$916,805	6,002	-36.3%	Shares	Sole	2026-05-04
2025-12-31	$1,299,424	9,425	+0.3%	Shares	Sole	2026-02-04
2025-09-30	$1,205,584	9,401	-16.6%	Shares	Sole	2025-11-04
2025-06-30	$1,363,903	11,271	-9.7%	Shares	Sole	2025-08-06
2025-03-31	$1,391,939	12,486	-3.1%	Shares	Sole	2025-05-02
2024-12-31	$1,253,742	12,884	+0.8%	Shares	Sole	2025-02-05
2024-09-30	$1,470,415	12,784	-1.6%	Shares	Sole	2024-10-25
2024-06-30	$1,383,447	12,995	+2.2%	Shares	Sole	2024-07-30
2024-03-31	$1,230,502	12,721	-1.4%	Shares	Sole	2024-05-02
2023-12-31	$1,302,613	12,901	-2.8%	Shares	Sole	2024-02-02
2023-09-30	$1,351,885	13,272	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.